# CRHR1

## Overview
The CRHR1 gene encodes the corticotropin-releasing hormone receptor 1, a G-protein-coupled receptor (GPCR) that plays a pivotal role in the body's response to stress. This receptor is primarily involved in the hypothalamic-pituitary-adrenal (HPA) axis, where it mediates the effects of corticotropin-releasing hormone (CRH) by facilitating the secretion of adrenocorticotropic hormone (ACTH) from the pituitary gland, ultimately leading to cortisol release from the adrenal cortex (Graf2012Corticotropinreleasing; Wang2022CRHR1). CRHR1 is widely expressed in the central nervous system, particularly in regions such as the cerebral cortex, amygdala, and hippocampus, where it influences stress-related behaviors and neuroendocrine functions (Graf2012Corticotropinreleasing). The receptor's activation triggers a cascade of intracellular signaling pathways, including the stimulation of adenylyl cyclase and subsequent cAMP production, which are crucial for various physiological processes (Wu2011Activation). Given its significant role in stress response and its involvement in psychiatric disorders, CRHR1 is a critical target for understanding and potentially treating conditions such as major depressive disorder and posttraumatic stress disorder (Lind2015CorticotropinReleasing).

## Structure
CRHR1, a corticotropin-releasing hormone receptor, is a G-protein-coupled receptor (GPCR) primarily expressed in the brain, including regions such as the hippocampus, cortex, and cerebellum (Cacciola2010Cannabinoids). The primary structure of CRHR1 consists of a sequence of amino acids that form seven transmembrane alpha-helices, characteristic of GPCRs. These helices contribute to the receptor's secondary structure, which is crucial for its function in signal transduction.

The tertiary structure of CRHR1 includes distinct extracellular, transmembrane, and intracellular domains, which facilitate its interaction with ligands and intracellular signaling proteins. Post-translational modifications such as glycosylation and phosphorylation are common in CRHR1, potentially affecting its stability and function.

CRHR1 also exhibits splice variant isoforms, which can result in different functional properties. These isoforms may vary in their expression patterns and physiological roles, contributing to the receptor's involvement in diverse biological processes, including stress response and immune function (Lozovaya2003Chemical). The receptor's distribution and function in the central nervous system highlight its significance in modulating stress-related responses and neurodegenerative processes (Lozovaya2003Chemical).

## Function
CRHR1, or corticotropin-releasing hormone receptor 1, is a G protein-coupled receptor that plays a crucial role in the stress response by mediating the effects of corticotropin-releasing hormone (CRH). It is primarily involved in the hypothalamic-pituitary-adrenal (HPA) axis, where it facilitates the secretion of adrenocorticotropic hormone (ACTH) from the pituitary gland, which in turn stimulates cortisol release from the adrenal cortex (Graf2012Corticotropinreleasing; Wang2022CRHR1). CRHR1 is widely expressed in the brain, particularly in regions such as the cerebral cortex, amygdala, and hippocampus, where it influences stress-related behaviors and neuroendocrine functions (Graf2012Corticotropinreleasing).

At the molecular level, CRHR1 activation leads to the stimulation of adenylyl cyclase, resulting in increased intracellular cAMP levels, which activate protein kinase A (PKA) and other downstream signaling pathways (Tu2007CorticotropinReleasing; Wu2011Activation). This receptor also interacts with other signaling molecules, such as ERK1/2, to modulate various cellular processes, including gene expression and neurotransmitter release (Wu2011Activation). In enterochromaffin cells, CRHR1 activation is linked to serotonin release, highlighting its role in the gut-brain axis and stress-induced intestinal functions (Wu2011Activation).

## Clinical Significance
The CRHR1 gene is implicated in several psychiatric disorders due to its role in stress response regulation. Variations in CRHR1, such as single nucleotide polymorphisms (SNPs), have been associated with major depressive disorder (MDD), posttraumatic stress disorder (PTSD), and anxiety-related conditions. Specific SNPs, including rs110402, rs242924, and rs12944712, have been linked to altered cortisol reactivity and stress response, which are critical in the pathophysiology of these disorders (Lind2015CorticotropinReleasing; da2016Effects).

In the context of MDD, CRHR1 polymorphisms interact with environmental factors such as childhood abuse, influencing depression vulnerability. Certain haplotypes, like TAT and TCA, have been identified as protective against depression in individuals with a history of childhood trauma (Bradley2008Influence). The gene's interaction with the hypothalamic-pituitary-adrenal (HPA) axis is crucial, as dysregulation in this system is a hallmark of MDD (Liu2006Association).

CRHR1 variations are also associated with PTSD, with specific SNPs linked to increased PTSD symptoms following trauma exposure (Lind2015CorticotropinReleasing). These genetic factors underscore the importance of CRHR1 in stress-related psychopathologies and its potential as a target for therapeutic interventions.

## Interactions
CRHR1, or corticotropin-releasing hormone receptor 1, is known to physically interact with the V1b receptor through heterodimerization. This interaction has been demonstrated in HEK293 cells using techniques such as Bioluminescence Resonance Energy Transfer (BRET) and coimmunoprecipitation. These studies show that CRHR1 and V1b receptors are in close proximity and can form heterodimers, which are crucial for mediating synergistic biological actions of vasopressin (AVP) and corticotropin-releasing hormone (CRH) (Murat2012V1b).

The heterodimerization of CRHR1 with V1b receptors influences the signaling pathways, including the potentiation of CRH-stimulated cAMP accumulation by AVP. This interaction is specific and involves multiple signaling pathways, such as those mediated by phospholipase C (PLC) and protein kinase C (PKC) (Murat2012V1b). The presence of CRHR1 can also affect the localization and functionality of V1b receptors, as shown by the action of a CRHR1-specific pharmacological chaperone, SSR125543, which rescues V1b receptors to the plasma membrane (Murat2012V1b).

CRHR1 also interacts with β-arrestins, which are involved in its desensitization and internalization upon ligand stimulation. This interaction is crucial for the receptor's internalization and subsequent signaling, particularly in the context of cAMP production (Inda2016Different).


## References


[1. (Graf2012Corticotropinreleasing) Cornelia Graf, Claudia Kuehne, Markus Panhuysen, Benno Puetz, Peter Weber, Florian Holsboer, Wolfgang Wurst, and Jan M. Deussing. Corticotropin-releasing hormone regulates common target genes with divergent functions in corticotrope and neuronal cells. Molecular and Cellular Endocrinology, 362(1–2):29–38, October 2012. URL: http://dx.doi.org/10.1016/j.mce.2012.05.007, doi:10.1016/j.mce.2012.05.007. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2012.05.007)

[2. (Lind2015CorticotropinReleasing) Mackenzie J. Lind, Chelsea Sawyers, Christina Sheerin, and Ananda B. Amstadter. Corticotropin-Releasing Hormone Receptor 1 (CRHR1) Polymorphisms and Posttraumatic Stress Disorder, pages 1–19. Springer International Publishing, 2015. URL: http://dx.doi.org/10.1007/978-3-319-08613-2_9-2, doi:10.1007/978-3-319-08613-2_9-2. This article has 0 citations.](https://doi.org/10.1007/978-3-319-08613-2_9-2)

[3. (Lozovaya2003Chemical) Natalya Lozovaya and Andrew D. Miller. Chemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic‐hypothalamic‐pituitary‐adrenal) systems. ChemBioChem, 4(6):466–484, June 2003. URL: http://dx.doi.org/10.1002/cbic.200200492, doi:10.1002/cbic.200200492. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cbic.200200492)

[4. (Tu2007CorticotropinReleasing) Hong Tu, Abba J. Kastin, and Weihong Pan. Corticotropin-releasing hormone receptor (crhr)1 and crhr2 are both trafficking and signaling receptors for urocortin. Molecular Endocrinology, 21(3):700–711, March 2007. URL: http://dx.doi.org/10.1210/ME.2005-0503, doi:10.1210/me.2005-0503. This article has 42 citations.](https://doi.org/10.1210/ME.2005-0503)

[5. (Liu2006Association) Zhongchun Liu, Fan Zhu, Gaohua Wang, Zheman Xiao, Huiling Wang, Jihua Tang, Xiaoping Wang, Desheng Qiu, Wanhong Liu, Zhijian Cao, and Wenxin Li. Association of corticotropin-releasing hormone receptor1 gene snp and haplotype with major depression. Neuroscience Letters, 404(3):358–362, September 2006. URL: http://dx.doi.org/10.1016/j.neulet.2006.06.016, doi:10.1016/j.neulet.2006.06.016. This article has 111 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.neulet.2006.06.016)

[6. (Inda2016Different) Carolina Inda, Paula A. dos Santos Claro, Juan J. Bonfiglio, Sergio A. Senin, Giuseppina Maccarrone, Christoph W. Turck, and Susana Silberstein. Different camp sources are critically involved in g protein–coupled receptor crhr1 signaling. Journal of Cell Biology, 214(2):181–195, July 2016. URL: http://dx.doi.org/10.1083/jcb.201512075, doi:10.1083/jcb.201512075. This article has 61 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1083/jcb.201512075)

[7. (da2016Effects) Bruna S. da Silva, Diego L. Rovaris, Jaqueline B. Schuch, Nina R. Mota, Renata B. Cupertino, Angelita P. Aroche, Guilherme P. Bertuzzi, Rafael G. Karam, Eduardo S. Vitola, Luciana Tovo-Rodrigues, Eugenio H. Grevet, and Claiton H.D. Bau. Effects of corticotropin-releasing hormone receptor 1 snps on major depressive disorder are influenced by sex and smoking status. Journal of Affective Disorders, 205:282–288, November 2016. URL: http://dx.doi.org/10.1016/j.jad.2016.08.008, doi:10.1016/j.jad.2016.08.008. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jad.2016.08.008)

[8. (Bradley2008Influence) Rebekah G. Bradley, Elisabeth B. Binder, Michael P. Epstein, Yilang Tang, Hemu P. Nair, Wei Liu, Charles F. Gillespie, Tiina Berg, Mark Evces, D. Jeffrey Newport, Zachary N. Stowe, Christine M. Heim, Charles B. Nemeroff, Ann Schwartz, Joseph F. Cubells, and Kerry J. Ressler. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Archives of General Psychiatry, 65(2):190, February 2008. URL: http://dx.doi.org/10.1001/archgenpsychiatry.2007.26, doi:10.1001/archgenpsychiatry.2007.26. This article has 506 citations.](https://doi.org/10.1001/archgenpsychiatry.2007.26)

[9. (Wu2011Activation) S. Vincent Wu, Pu-Qing Yuan, Jim Lai, Kelvin Wong, Monica C. Chen, Gordon V. Ohning, and Yvette Taché. Activation of type 1 crh receptor isoforms induces serotonin release from human carcinoid bon-1n cells: an enterochromaffin cell model. Endocrinology, 152(1):126–137, January 2011. URL: http://dx.doi.org/10.1210/en.2010-0997, doi:10.1210/en.2010-0997. This article has 29 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1210/en.2010-0997)

[10. (Cacciola2010Cannabinoids) Giovanna Cacciola, Rosanna Chianese, Teresa Chioccarelli, Vincenza Ciaramella, Silvia Fasano, Riccardo Pierantoni, Rosaria Meccariello, and Gilda Cobellis. Cannabinoids and reproduction: a lasting and intriguing history. Pharmaceuticals, 3(10):3275–3323, October 2010. URL: http://dx.doi.org/10.3390/ph3103275, doi:10.3390/ph3103275. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ph3103275)

[11. (Murat2012V1b) Brigitte Murat, Dominic Devost, Miriam Andrés, Julie Mion, Véra Boulay, Maithé Corbani, Hans H. Zingg, and Gilles Guillon. V1b and crhr1 receptor heterodimerization mediates synergistic biological actions of vasopressin and crh. Molecular Endocrinology, 26(3):502–520, March 2012. URL: http://dx.doi.org/10.1210/me.2011-1202, doi:10.1210/me.2011-1202. This article has 41 citations.](https://doi.org/10.1210/me.2011-1202)

[12. (Wang2022CRHR1) Tong Ying Wang, Fang Yuan Xia, Jing Wen Gong, Xiao Kang Xu, Min Chao Lv, Mahanand Chatoo, Bilal Haider Shamsi, Meng Chen Zhang, Qian Ru Liu, Tian Xing Liu, Dan Dan Zhang, Xin Jiang Lu, Yang Zhao, Ji Zeng Du, and Xue Qun Chen. Crhr1 mediates the transcriptional expression of pituitary hormones and their receptors under hypoxia. Frontiers in Endocrinology, September 2022. URL: http://dx.doi.org/10.3389/fendo.2022.893238, doi:10.3389/fendo.2022.893238. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2022.893238)